Table 2.
Tissue | Parameter | 5-HT | Bufotenin | Tryptamine | Tryptamine + pargyline |
---|---|---|---|---|---|
LA | Force of contraction |
7.94 ± 0.32 N = 4 |
6.77 ± 0.52 * N = 5 |
4.57 ± 0.92 *# N = 5 |
5.48 ± 0.64 *# N = 5 |
LA | TTP |
8.07 ± 0.24 N = 5 |
6.45 ± 0.47 * N = 5 |
5.18 ± 0.53 *# N = 5 |
6.12 ± 0.38 *+ N = 5 |
LA | TR |
8.62 ± 0.83 N = 4 |
6.31 ± 1.65 * N = 5 |
5.54 ± 0.87 * N = 5 |
6.45 ± 0.99 N = 5 |
LA | dF/dtmax |
7.87 ± 0.25 N = 4 |
6.9 ± 0.73 * N = 5 |
4.73 ± 0.89 *# N = 7 |
5.47 ± 0.59 *# N = 5 |
LA | dF/dtmin |
7.91 ± 0.34 N = 4 |
6.92 ± 0.7 * N = 5 |
4.73 ± 0.79 *# N = 7 |
5.51 ± 0.45 *#+ N = 5 |
RA | Beating rate |
7.05 ± 5.02 N = 4 |
7.04 ± 1.08 N = 6 |
5.27 ± 0.53 *# N = 5 |
5.98 ± 1.63 * N = 5 |
LA left atrium, RA right atrium, TTP time to peak, TR time of relaxation, dF/dt maximum and minimum of the first derivative of force of contraction. ANOVA: *p < 0.05 vs. 5-HT; #p < 0.05 vs. bufotenin; +p < 0.05 vs. tryptamine